New shot could help lower stubborn high cholesterol
NCT ID NCT07278830
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new injectable drug called SAL003, given together with the common cholesterol pill atorvastatin, in 214 adults with high cholesterol or mixed dyslipidemia. The goal was to see if the combination lowers 'bad' LDL cholesterol more than atorvastatin alone. Participants received either SAL003 or a placebo shot every few weeks for 24 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University，Guangzhou，Guangdong，510120
Guangzhou, Guangdong, 510120, China